vs
ENERPAC TOOL GROUP CORP（EPAC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
ENERPAC TOOL GROUP CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$144.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -0.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $13.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 2.1%）
恩派克工具集团前身为Actuant公司，成立于1910年，总部位于美国威斯康星州梅诺莫尼福尔斯，是一家历史悠久的工业工具企业，其普通股在纽约证券交易所上市，股票代码为EPAC。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EPAC vs PBYI — 直观对比
营收规模更大
EPAC
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出28.4%
-0.7%
自由现金流更多
PBYI
多$1.1M
$13.3M
两年增速更快
PBYI
近两年复合增速
2.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $144.2M | $75.5M |
| 净利润 | $19.1M | — |
| 毛利率 | 50.7% | 69.3% |
| 营业利润率 | 19.8% | 22.7% |
| 净利率 | 13.3% | — |
| 营收同比 | -0.7% | 27.7% |
| 净利润同比 | -11.9% | — |
| 每股收益（稀释后） | $0.36 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPACPBYI
| Q4 25 | $144.2M | $75.5M | ||
| Q3 25 | $167.5M | $54.5M | ||
| Q2 25 | $158.7M | $52.4M | ||
| Q1 25 | $145.5M | $46.0M | ||
| Q4 24 | $145.2M | $59.1M | ||
| Q3 24 | $158.7M | $80.5M | ||
| Q2 24 | $150.4M | $47.1M | ||
| Q1 24 | $138.4M | $43.8M |
净利润EPACPBYI
| Q4 25 | $19.1M | — | ||
| Q3 25 | $28.1M | $8.8M | ||
| Q2 25 | $22.0M | $5.9M | ||
| Q1 25 | $20.9M | $3.0M | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $24.4M | $20.3M | ||
| Q2 24 | $25.8M | $-4.5M | ||
| Q1 24 | $17.8M | $-4.8M |
毛利率EPACPBYI
| Q4 25 | 50.7% | 69.3% | ||
| Q3 25 | 50.1% | 77.7% | ||
| Q2 25 | 50.4% | 76.5% | ||
| Q1 25 | 50.5% | 77.1% | ||
| Q4 24 | 51.4% | 76.4% | ||
| Q3 24 | 48.8% | 63.9% | ||
| Q2 24 | 51.8% | 77.4% | ||
| Q1 24 | 51.6% | 75.5% |
营业利润率EPACPBYI
| Q4 25 | 19.8% | 22.7% | ||
| Q3 25 | 23.8% | 17.6% | ||
| Q2 25 | 20.0% | 12.7% | ||
| Q1 25 | 21.2% | 8.7% | ||
| Q4 24 | 21.4% | 22.6% | ||
| Q3 24 | 18.9% | 27.4% | ||
| Q2 24 | 22.2% | -4.6% | ||
| Q1 24 | 21.3% | -5.3% |
净利率EPACPBYI
| Q4 25 | 13.3% | — | ||
| Q3 25 | 16.8% | 16.2% | ||
| Q2 25 | 13.9% | 11.2% | ||
| Q1 25 | 14.4% | 6.5% | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 15.4% | 25.2% | ||
| Q2 24 | 17.1% | -9.6% | ||
| Q1 24 | 12.9% | -11.0% |
每股收益（稀释后）EPACPBYI
| Q4 25 | $0.36 | $0.26 | ||
| Q3 25 | $0.51 | $0.17 | ||
| Q2 25 | $0.41 | $0.12 | ||
| Q1 25 | $0.38 | $0.06 | ||
| Q4 24 | $0.40 | $0.40 | ||
| Q3 24 | $0.44 | $0.41 | ||
| Q2 24 | $0.47 | $-0.09 | ||
| Q1 24 | $0.33 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $139.0M | $97.5M |
| 总债务越低越好 | $188.8M | $22.7M |
| 股东权益账面价值 | $431.1M | $130.3M |
| 总资产 | $818.1M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.44× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EPACPBYI
| Q4 25 | $139.0M | $97.5M | ||
| Q3 25 | $151.6M | $94.4M | ||
| Q2 25 | $140.5M | $96.0M | ||
| Q1 25 | $119.5M | $93.2M | ||
| Q4 24 | $130.7M | $101.0M | ||
| Q3 24 | $167.1M | $96.7M | ||
| Q2 24 | $132.4M | $96.8M | ||
| Q1 24 | $153.7M | $107.2M |
总债务EPACPBYI
| Q4 25 | $188.8M | $22.7M | ||
| Q3 25 | $190.0M | $34.0M | ||
| Q2 25 | $191.3M | $45.3M | ||
| Q1 25 | $192.5M | $56.7M | ||
| Q4 24 | $193.8M | $68.0M | ||
| Q3 24 | $195.0M | $79.3M | ||
| Q2 24 | $196.3M | $90.7M | ||
| Q1 24 | $245.5M | $102.0M |
股东权益EPACPBYI
| Q4 25 | $431.1M | $130.3M | ||
| Q3 25 | $433.7M | $115.3M | ||
| Q2 25 | $438.2M | $104.7M | ||
| Q1 25 | $406.0M | $97.1M | ||
| Q4 24 | $398.0M | $92.1M | ||
| Q3 24 | $392.0M | $71.1M | ||
| Q2 24 | $365.8M | $48.5M | ||
| Q1 24 | $336.9M | $51.0M |
总资产EPACPBYI
| Q4 25 | $818.1M | $216.3M | ||
| Q3 25 | $827.9M | $202.9M | ||
| Q2 25 | $828.1M | $194.9M | ||
| Q1 25 | $776.6M | $196.2M | ||
| Q4 24 | $775.4M | $213.3M | ||
| Q3 24 | $777.3M | $220.7M | ||
| Q2 24 | $749.5M | $205.0M | ||
| Q1 24 | $769.3M | $214.1M |
负债/权益比EPACPBYI
| Q4 25 | 0.44× | 0.17× | ||
| Q3 25 | 0.44× | 0.30× | ||
| Q2 25 | 0.44× | 0.43× | ||
| Q1 25 | 0.47× | 0.58× | ||
| Q4 24 | 0.49× | 0.74× | ||
| Q3 24 | 0.50× | 1.12× | ||
| Q2 24 | 0.54× | 1.87× | ||
| Q1 24 | 0.73× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $13.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 9.2% | 19.1% |
| 资本支出强度资本支出/营收 | 1.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.84× | — |
| 过去12个月自由现金流最近4个季度 | $102.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流EPACPBYI
| Q4 25 | $16.0M | $14.4M | ||
| Q3 25 | $55.3M | $9.7M | ||
| Q2 25 | $39.9M | $14.1M | ||
| Q1 25 | $7.5M | $3.6M | ||
| Q4 24 | $8.6M | $15.6M | ||
| Q3 24 | $44.4M | $11.0M | ||
| Q2 24 | $30.3M | $1.0M | ||
| Q1 24 | $13.3M | $11.2M |
自由现金流EPACPBYI
| Q4 25 | $13.3M | $14.4M | ||
| Q3 25 | $52.3M | $9.7M | ||
| Q2 25 | $35.1M | $14.1M | ||
| Q1 25 | $1.8M | $3.6M | ||
| Q4 24 | $2.8M | $15.6M | ||
| Q3 24 | $37.9M | $11.0M | ||
| Q2 24 | $28.5M | $1.0M | ||
| Q1 24 | $11.7M | — |
自由现金流率EPACPBYI
| Q4 25 | 9.2% | 19.1% | ||
| Q3 25 | 31.2% | 17.7% | ||
| Q2 25 | 22.1% | 26.8% | ||
| Q1 25 | 1.2% | 7.7% | ||
| Q4 24 | 1.9% | 26.4% | ||
| Q3 24 | 23.9% | 13.7% | ||
| Q2 24 | 18.9% | 2.1% | ||
| Q1 24 | 8.5% | — |
资本支出强度EPACPBYI
| Q4 25 | 1.9% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 3.1% | 0.0% | ||
| Q1 25 | 3.9% | 0.1% | ||
| Q4 24 | 4.0% | 0.0% | ||
| Q3 24 | 4.1% | 0.0% | ||
| Q2 24 | 1.2% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
现金转化率EPACPBYI
| Q4 25 | 0.84× | — | ||
| Q3 25 | 1.97× | 1.10× | ||
| Q2 25 | 1.81× | 2.41× | ||
| Q1 25 | 0.36× | 1.21× | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 1.82× | 0.54× | ||
| Q2 24 | 1.18× | — | ||
| Q1 24 | 0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPAC
| Transferred At Point In Time | $126.0M | 87% |
| Other | $12.1M | 8% |
| Other Operating Segment | $6.1M | 4% |
PBYI
暂无分部数据
